Reinfection by SARS CoV2 in Valle Del Cauca, Colombia: A Descriptive Retrospective Study

Inquiry. 2022 Jan-Dec:59:469580221096528. doi: 10.1177/00469580221096528.

Abstract

Introduction: In coronavirus cases, reinfection has been associated with short-term immunity and genetic changes in viruses which allow them to escape from immune response, viral genotyping is required to make the precise diagnosis of reinfection, but the suspicion occurs in patients with more than 90 days between the tests and total improvement between them. We made a descriptive retrospective study with the cases of reinfection in Valle del Cauca, Colombia. Results: We found up to June 30, 3249 cases with suspected reinfection, 1.1% of all cases. During the first infection episode, 68% of the patients had symptoms, while at the moment of reinfection, the percentage was 73.4%. 55% of the analyzed cases had symptoms in both infection episodes, hospitalization of reinfection cases was 2% during the first episode and 2.2% in the second one. Conclusion: the reinfection percentage was low, as well as the hospitalization and ICU cases. These results allow to define that in terms of the provision of healthcare services, reinfection defined in this study, does not generate any differences in care required vs the first episode.

Keywords: COVID-19; Colombia; SARS CoV2; reinfection; retrospective studies.

MeSH terms

  • COVID-19*
  • Colombia / epidemiology
  • Humans
  • Reinfection / epidemiology
  • Retrospective Studies
  • Severe Acute Respiratory Syndrome*